| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 820NH671E6 |
| InChI Key | DOTGPNHGTYJDEP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H19N7O2 |
| Molecular Weight | 365.4 |
| AlogP | 2.22 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 134.76 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Serine/threonine-protein kinase Chk1 inhibitor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Medulloblastoma | 1 | D008527 | ClinicalTrials |
| Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
| Leukemia, Myelomonocytic, Chronic | 1 | D015477 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Brain Neoplasms | 1 | D001932 | ClinicalTrials |
| Glioma | 1 | D005910 | ClinicalTrials |
| Carcinoma, Squamous Cell | 1 | D002294 | ClinicalTrials |
| Carcinoma, Squamous Cell | 1 | D002294 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1234015-52-1 |
| ChEMBL | CHEMBL3544911 |
| DrugBank | DB12008 |
| FDA SRS | 820NH671E6 |
| Guide to Pharmacology | 9549 |
| PubChem | 46700756 |
| SureChEMBL | SCHEMBL1975451 |
| ZINC | ZINC000095837013 |